Effects of arctiin on streptozotocin-induced diabetic retinopathy in sprague-dawley rats

Planta Medica

Volumn 78, Issue 12, 2012, Pages 1317-1323

  Lu, Lai Chun ^a   Zhou, Wei ^a   Li, Zhuo Heng ^a   Yu, Cai Ping ^a   Li, Chen Wen ^a   Luo, Ming He ^a   Xie, Hong ^b  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

arctiin; diabetic retinopathy; HBA1c; retina; retinal microvascular endothelial cell

Indexed keywords

ARCTIIN; CARBOXYMETHYLCELLULOSE; DOBESILATE CALCIUM; GLUCOSE; HEMOGLOBIN A1C; STREPTOZOCIN; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARCTIUM; ARTICLE; BLOOD VISCOSITY; CELL VIABILITY; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DIABETIC RETINOPATHY; DISEASE SEVERITY; DRUG EFFECT; DRUG MEGADOSE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HISTOLOGY; IMMUNOCHEMISTRY; IN VITRO STUDY; LOW DRUG DOSE; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; RETINA DETACHMENT; RETINA MACULA EDEMA; SHAM PROCEDURE; SPRAGUE DAWLEY RAT; STREPTOZOCIN DIABETES;

ANIMALS; ARCTIUM; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC RETINOPATHY; DRUGS, CHINESE HERBAL; FURANS; GLUCOSIDES; HEMOGLOBIN A, GLYCOSYLATED; HYPOGLYCEMIC AGENTS; MALE; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; SEEDS; STREPTOZOCIN;

ARCTIUM LAPPA; RATTUS;

EID: 84865254033     PISSN: 00320943     EISSN: 14390221     Source Type: Journal    
DOI: 10.1055/s-0032-1314998     Document Type: Article

References (27)

1. Alghadyan AA. Diabetic retinopathy - An update. Saudi J Ophthalmol: 2011; 25 99 111
2. Zhao F, Wang L, Liu K. In vitro anti-inflammatory effects of arctigenin, a lignan from Arctium lappa L., through inhibition on iNOS pathway. J Ethnopharmacol: 2009; 122 457 462
3. Wu JG, Wu JZ, Sun LN, Han T, Du J, Ye Q, Zhang H, Zhang YG. Ameliorative effects of arctiin from Arctium lappa on experimental glomerulonephritis in rats. Phytomedicine: 2009; 16 1033 1041
4. Hirose M, Yamaguchi T, Lin C, Kimoto N, Futakuchi M, Kono T, Nishibe S, Shirai T. Effects of arctiin on PhIP-induced mammary, colon and pancreatic carcinogenesis in female Sprague-Dawley rats and MeIQx-induced hepatocarcinogenesis in male F344 rats. Cancer Lett: 2000; 155 79 88 (Pubitemid 30256228)
5. Ozturk BT, Bozkurt B, Kerimoglu H, Okka M, Kamis U, Gunduz K. Effect of serum cytokines and VEGF levels on diabetic retinopathy and macular thickness. Mol Vis: 2009; 15 1906 1914
6. Izuta H, Chikaraishi Y, Adachi T, Shimazawa M, Sugiyama T, Ikeda T, Hara H. Extracellular SOD and VEGF are increased in vitreous bodies from proliferative diabetic retinopathy patients. Mol Vis: 2009; 15 2663 2672
7. Drel VR, Xu WZ, Zhang J, Kador PF, Ali TK, Shin J, Julius U, Slusher B, Remessy AB, Obrosova IG. Poly (ADP-Ribose) polymerase inhibition counteracts cataract formation and early retinal changes in streptozotocin-diabetic rats. Invest Ophthalmol Vis Sci: 2012; 53 1778 1790
8. Badole SL, Bodhankar SL. Investigation of antihyperglycaemic activity of aqueous and petroleum ether extract of stem bark of Pongamia pinnata on serum glucose level in diabetic mice. J Ethnopharmacol: 2009; 123 115 120
9. Mirshafiey A, Mehrabian F, Razavi A, Shidfar MR, Namaki S. Novel therapeutic approach by culture filtrate of Cryptococcus neoformans var. gattii (CneF) in experimental immune complex glomerulonephritis. Gen Pharmacol: 2000; 34 311 319
10. Silverman MD, Zamora DO, Pan Y, Texeira PV, Planck SR, Rosenbaum JT. Cell adhesion molecule expression in cultured human iris endothelial cells. Invest Ophthalmol Vis Sci: 2001; 42 2861 2866 (Pubitemid 33035284)
11. Silverman MD, Zamora DO, Pan Y, Texeira PV, Baek SH, Planck SR, Rosenbaum JT. Constitutive and inflammatory mediatorregulated fractalkine expression in human ocular tissues and cultured cells. Invest Ophthalmol Vis Sci: 2003; 44 1608 1615 (Pubitemid 36378588)
12. Jain A, Sarraf D, Fong D. Preventing diabetic retinopathy through control of systemic factors. Curr Opin Ophthalmol: 2003; 14 389
13. Ola MS, Nawaz M, Siddiquei MM, Amro SA, El-Asrar AM. Recent advances in understanding the biochemical and molecular mechanism of diabetic retinopathy. J Diabetes Complications: 2012; 10.1016/j.jdiacomp.2011.11.004, published online 10.1016/j.jdiacomp.2011.11.004
14. Amanda IA, Brian S, Charles H, Lalantha L, Diana B. Hyperglycemia and death in cystic fibrosis-related diabetes. Diabetes Care: 2011; 34 1577 1578
15. Warboys CM, Fraser PA. Hyperglycemia attenuates acute permeability response to advanced glycation end products in retinal microvasculature. Microvasc Res: 2010; 80 174 176
16. Angela G, Holger H, Andrea N, Sabine H, Martin H, Klemens R, Reinhard WH. Natural course of untreated microalbuminuria in children and adolescents with type 1 diabetes and the importance of diabetes duration and immigrant status: longitudinal analysis from the prospective nationwide German and Austrian diabetes survey DPV. Eur J Endocrinol: 2012; 28 2019 2024
17. Ciulla TA, Amador AG, Zinman B. Diabetic retinopathy and diabetic macular edema. Diabetes Care: 2003; 26 2653
18. Xiang X, Ji PC, Jia JX, Ruo BW, Jian MC, Yun L, Wei GX, Xue JS, Run PL. Protective effects of hydrogen saline on diabetic retinopathy in a streptozotocin-induced diabetic rat model. J Ocul Pharmacol Ther: 2012; 28 76 82
19. Curtis TM, Gardiner TA, Stitt AW. Microvascular lesions of diabetic retinopathy: clues towards understanding pathogenesis? Eye: 2009; 23 1496 1508
20. Krishnamurti U, Steffes MW. Glycohemoglobin: a primary predictor of the development or reversal of complications of diabetes mellitus. Clin Chem: 2001; 47 1157
21. Tapp RJ, Tikellis G, Wong TY, Harper CA, Zimmet PZ, Shaw JE. Longitudinal association of glucose metabolism with retinopathy. Diabetes Care: 2008; 31 1349
22. Sabanayagam C, Liew G, Tai ES, Lim SC, Subramaniam T, Wong TY. Relationship between glycated aemoglobin and microvascular complications: is there a natural cut-off point for the diagnosis of diabetes? Diabetologia: 2009; 52 1279 1289
23. Suganthalakshmi B, Anand R, Kim R, Mahalakshmi R, Karthikprakash S, Namperumalsamy P, Sundaresan P. Association of VEGF and eNOS gene polymorphisms in type 2 diabetic retinopathy. Mol Vis: 2006; 12 336 341
24. Kou X, Qi S, Dai W, Luo L, Yin Z. Arctigenin inhibits lipopolysaccharide-induced iNOS expression in RAW264. 7 cells through suppressing JAK-STAT signal pathway. Int Immunopharmacol: 2011; 11 1095 1102
25. Velcheva I, Damianov P, Mantarova S, Antonova N. Hemorheology and heart rate variability in patients with diabetes mellitus type 2. Clin Hemorheol Microcirc: 2011; 49 513 518
26. Salazar-Vazquez BY, Intaglietta M, Rodríguez-Morán M, Guerrero-Romero F. Blood pressure and hematocrit in diabetes and the role of endothelial responses in the variability of blood viscosity. Diabetes Care: 2006; 29 1523
27. Junguk H, Kelli S, Adam S, Yu H, Manjusha P, David S, Jagadish HV, Feldman EL. Literature-based discovery of diabetes-and ROS-related targets. BMC Med Genomics: 2010; 3 49